NEU 0.00% $19.97 neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-149

  1. 6,392 Posts.
    lightbulb Created with Sketch. 683
    Just going back to your earlier points within this post.

    You and I have danced around autism for some time. My ears pricked initially when we were granted a patent in Israel.

    I'd like to know (from anyone). Has anyone ever gone to the FDA and requested that four phase 2 trials be combined so that one phase 3 trial can be initiated to cover all of the spectrums?

    Because if that was possible. Thats my go to. 1 trial (self funded) that covers 4 spectrums.
    If you pass, these talks of $200 become real.

    If it cant be done, then let's sell and move on. We aren't funding four Ph 3 trials. We just aren't.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.97
Change
0.000(0.00%)
Mkt cap ! $2.552B
Open High Low Value Volume
$19.96 $19.97 $19.69 $4.156M 209.6K

Buyers (Bids)

No. Vol. Price($)
1 246 $19.88
 

Sellers (Offers)

Price($) Vol. No.
$19.99 512 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.